mmm-online.com
Sheeza Hussain, chief commercial officer for remote patient monitoring firm
Biofourmis, discusses commercial strategies in digital medicine during what’s
been a relatively quiet investment period for health tech.
about 4 years ago
mmm-online.com
Dr. Harshit Jain, a 2021 MM+M 40 Under 40 honoree, pressed marketers to remain
open to how data can influence their work.
about 4 years ago
mmm-online.com
Creating a path forward through creative and strategic data-based decisions.
about 4 years ago
mmm-online.com
CDC says 3.2 million Americans got updated COVID boosters last week; FDA’s
accelerated approval pathway faces criticism for pharma ties; Pfizer CEO pulls
out of testifying to EU Parliament COVID panel.
about 4 years ago
mmm-online.com
J&J decides to halt Phase I clinical trial of Essa Pharma’s prostate cancer
drug; U.S. could have first RSV vaccine by 2023 season; Lebanon receives first
cholera vaccines from France.
about 4 years ago
mmm-online.com
Vertex’s nonaddictive painkiller candidate shows promise as an alternative to
opioids; New cancer drug prices rise 53% since 2017; Unity Biotechnology’s
diabetic macular edema drug to move into pivotal study next year.
about 4 years ago
mmm-online.com
Several other healthcare companies reported, including Agios, SpringWorks and
Bausch Health.
about 4 years ago
